SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Thomas J Pittman who wrote (11227)8/16/1999 5:25:00 PM
From: Thomas J Pittman  Read Replies (2) | Respond to of 17367
 
Castello..........detailed analysis will take a few weeks
but wanted to say something instead of waiting.

Primary objective to get drug approved.
We believe that there is a clinical beneift based on data
393 patients, no safety concerns
FDA has seen limited preliminary data
BLA is in preparation
No discussion of trial results until FDA meeting

.............



To: Thomas J Pittman who wrote (11227)8/16/1999 5:26:00 PM
From: opalapril  Respond to of 17367
 
JC repeats guarded optimism but says he doesn't want to say any more until after FDA meeting


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News